Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Seres Therapeutics Inc
NASDAQ:MCRB
Seres Therapeutics Inc
NASDAQ:MCRB
Price:
2.85
USD
-3.06%
Market Cap:
$27.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Seres Therapeutics Inc
NASDAQ:MCRB
|
US |
|
Focus Graphite Inc
XTSX:FMS
|
CA |
|
European Medical Solutions SA
XBRU:ALEMS
|
FR |
Wall St Price Targets
MCRB Price Forecast
Based on 4 analysts
Based on 4 analysts
+508% Upside
from
$2.85
today
Seres Therapeutics Inc (MCRB)’s 12-month stock price forecast through October 2027 has a consensus target of $17.34, implying 508% upside. The forecast is based on price targets from 4 Wall Street analysts.
MCRB Analyst Rating
Based on 2 analysts
Based on 2 analysts
Analysts rate MCRB Strong buy, with 2 of 2 recommending Buy or Strong buy.
Seres Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MCRB's stock price target?
Price Target
17.34
USD
17.34
USD
According to Wall Street analysts, the average 1-year price target for MCRB is 17.34 USD with a low forecast of 12.12 USD and a high forecast of 23.1 USD.
What is the Revenue forecast for Seres Therapeutics Inc?
Projected CAGR
-29%
-29%
The compound annual growth rate for Revenue over the next 3 years is -29%.